Menu Back toSession-11-Post-Marketing-Safety-Principles-and-Spontaneous-Case-Reporting

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.

Session 11: Post-Marketing Safety Principles and Spontaneous Case Reporting

Session Chair(s)

Jill W. Buckley, PharmD

Jill W. Buckley, PharmD

  • Adjunct Assistant Professor
  • Rutgers, the State University of New Jersey, United States
This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.

Contact us

Registration Questions?

Send Email

Agenda and Event Logistics

Send Email